Frontlight ResearchEarly access
CompletedPhase 1
A clinical trial of MK-3868 in healthy participants (MK-3868-001)
Key facts
- Who runs it
- Merck Sharp & Dohme LLC
- Where
- Belgium1 site in 1 countryChoose a country to see its sites
- Trial code
- EU 2026-526674-17-00
- U1111-1339-5644
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 16 people enrolled
- Started
- 31 Jul 2026
- Ended
- 30 Oct 2026
- Type of study
- Interventional
- Record updated
- 27 July 2026
Who can take part
- Age
- 18 years to 64 years
- Sex
- Men only
- Healthy volunteers
- Can take part
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 27 July 2026